Abstract 5831: ABN202 (αTROP2), a sacituzumab-interferon-beta mutein fusion protein: a novel approach beyond antibody-drug conjugate therapeutics in ADC-naïve and ADC-refractory cancers
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Hee Geon Park, Hyun Kyung Lee, Myeung Ryun Seo, Soo Jin Ryu, Sungyoul Hong, Chan Gyu Lee, Hae Min Jeong, Sae Hyung Lee, Na Young Kim, Young Kee Shin, Jun Young Choi
Institution: Seoul National University
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409636652